Russian TB Vaccine Enters Phase III Trials
The Gamaleya Research Institute's tuberculosis vaccine has entered Phase III clinical trials, according to its scientific director, Alexander Gintsburg. This phase involves thousands of patients and aims to confirm the vaccine's benefits on a large scale. Statistical data processing is currently underway.4 sourcesSee all sources